Drug intelligence / Profile preview

CAR-T LeY

Development stage
Preclinical
Lead developer
Shanghai YaKe Biotechnology
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
Administration
Intravenous
01

Overview

CAR-T LeY is an investigational chimeric antigen receptor (CAR) T-cell therapy being developed by YaKe Biotechnology for the treatment of acute myeloid leukemia (AML). The therapy involves engineering a patient's T cells to express a CAR that specifically recognizes the Lewis Y (LeY) antigen, a carbohydrate antigen frequently overexpressed on the surface of various tumor cells, including those in AML. Upon reinfusion into the patient, these engineered CAR-T cells bind to LeY-expressing leukemic cells, leading to T-cell activation, expansion, and targeted cytotoxicity against the tumor. As of the latest pipeline information, the product is in the preclinical evaluation stage.

Other names
Lewis Y antigen CAR-T cell therapy
02

Targets

LeY (Lewis Y antigen)

Beyond the preview

Go deeper on CAR-T LeY.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAR-T LeY.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call